SCHEMBL7845184

SCHEMBL7845184

COC(=O)c1cccc2[nH]cc(C(=O)CCl)c12

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 10/20 0.62
▸ CREBBP Q92793 1/20 0.52
▸ MAPT P10636 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ MITF O75030 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ CTNNB1 P35222 1/20 0.44
▸ WNT3A P56704 1/20 0.44
▸ RIPK1 Q13546 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12750322 0.87 NR4A2 (0.59) NR4A2CREBBPMAPTLMNARAB9A
SCHEMBL28709469 0.83 NR4A2 (0.54) NR4A2CREBBPMAPTRAB9AMEN1
SCHEMBL27968725 0.82 NR4A2 (0.64) NR4A2CREBBPMAPTLMNARAB9A
SCHEMBL16686859 0.82 NR4A2 (0.64) NR4A2CREBBPLMNARAB9AALDH1A1
SCHEMBL8568555 0.82 LMNA (0.47) NR4A2MAPTLMNARAB9AMEN1
SCHEMBL5002424 0.81 NR4A2 (0.52) NR4A2CREBBPRAB9AMEN1KMT2A
SCHEMBL7842860 0.80 LMNA (0.54) NR4A2MAPTLMNARAB9AMEN1
SCHEMBL16686899 0.78 NR4A2 (0.58) NR4A2CREBBPMAPTLMNAMEN1
SCHEMBL7849247 0.78 NR4A2 (0.61) NR4A2MAPTLMNARAB9AMEN1
SCHEMBL29886596 0.78 NR4A2 (0.61) NR4A2CREBBPLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915280-B2 Compounds and their uses EISAI INC. (US) 2011-03-29 — — US disclosed
US-RE41150-E1 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one EISAI CORPORATION OF NORTH AMERICA (US) 2010-02-23 — — US disclosed
US-7235557-B2 Compounds and their uses MGI GP, INC. (US) 2007-06-26 — — US disclosed
US-7235557-B2 Compounds and their uses MGI GP, INC. (US) 2007-06-26 — — US disclosed
EP-0821685-B1 INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LAB (US) 2001-10-04 — — EP disclosed
EP-0821685-A1 INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1998-02-04 — — EP disclosed
WO-1996033196-A1 INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1996-10-24 — — WO disclosed
US-5567711-A Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists ABBOTT LABORATORIES (US) 1996-10-22 — — US disclosed
Send feedback